SANDS LAB Statistics
Total Valuation
SANDS LAB has a market cap or net worth of KRW 125.19 billion. The enterprise value is 91.44 billion.
| Market Cap | 125.19B |
| Enterprise Value | 91.44B |
Important Dates
The next estimated earnings date is Friday, May 15, 2026.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
SANDS LAB has 15.27 million shares outstanding. The number of shares has increased by 7.52% in one year.
| Current Share Class | 15.27M |
| Shares Outstanding | 15.27M |
| Shares Change (YoY) | +7.52% |
| Shares Change (QoQ) | +2.51% |
| Owned by Insiders (%) | 17.64% |
| Owned by Institutions (%) | n/a |
| Float | 6.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.78 |
| PB Ratio | 2.31 |
| P/TBV Ratio | 2.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 385.30 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -166.37 |
| EV / Sales | 7.87 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -338.80 |
Financial Position
The company has a current ratio of 10.00, with a Debt / Equity ratio of 0.00.
| Current Ratio | 10.00 |
| Quick Ratio | 9.49 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.03 |
| Interest Coverage | -5,001.04 |
Financial Efficiency
Return on equity (ROE) is -0.91% and return on invested capital (ROIC) is -2.17%.
| Return on Equity (ROE) | -0.91% |
| Return on Assets (ROA) | -2.04% |
| Return on Invested Capital (ROIC) | -2.17% |
| Return on Capital Employed (ROCE) | -3.26% |
| Weighted Average Cost of Capital (WACC) | 7.04% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.21 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SANDS LAB has paid 428.44 million in taxes.
| Income Tax | 428.44M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.62% in the last 52 weeks. The beta is 0.51, so SANDS LAB's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | -4.62% |
| 50-Day Moving Average | 6,519.20 |
| 200-Day Moving Average | 7,704.75 |
| Relative Strength Index (RSI) | 71.99 |
| Average Volume (20 Days) | 868,844 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SANDS LAB had revenue of KRW 11.61 billion and -549.64 million in losses. Loss per share was -36.00.
| Revenue | 11.61B |
| Gross Profit | 11.61B |
| Operating Income | -1.77B |
| Pretax Income | -37.02M |
| Net Income | -549.64M |
| EBITDA | -632.81M |
| EBIT | -1.77B |
| Loss Per Share | -36.00 |
Balance Sheet
The company has 34.01 billion in cash and 8.91 million in debt, with a net cash position of 34.00 billion or 2,227.17 per share.
| Cash & Cash Equivalents | 34.01B |
| Total Debt | 8.91M |
| Net Cash | 34.00B |
| Net Cash Per Share | 2,227.17 |
| Equity (Book Value) | 54.27B |
| Book Value Per Share | 3,451.48 |
| Working Capital | 33.71B |
Cash Flow
In the last 12 months, operating cash flow was 324.93 million and capital expenditures -594.83 million, giving a free cash flow of -269.90 million.
| Operating Cash Flow | 324.93M |
| Capital Expenditures | -594.83M |
| Depreciation & Amortization | 1.14B |
| Net Borrowing | -16.45M |
| Free Cash Flow | -269.90M |
| FCF Per Share | -17.68 |
Margins
Gross margin is 100.00%, with operating and profit margins of -15.25% and -4.73%.
| Gross Margin | 100.00% |
| Operating Margin | -15.25% |
| Pretax Margin | -0.32% |
| Profit Margin | -4.73% |
| EBITDA Margin | -5.45% |
| EBIT Margin | -15.25% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 150.00, which amounts to a dividend yield of 1.91%.
| Dividend Per Share | 150.00 |
| Dividend Yield | 1.91% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -7.52% |
| Shareholder Yield | -5.60% |
| Earnings Yield | -0.44% |
| FCF Yield | -0.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SANDS LAB has an Altman Z-Score of 21.89 and a Piotroski F-Score of 2.
| Altman Z-Score | 21.89 |
| Piotroski F-Score | 2 |